Wyeth Consumer Healthcare, a division of Wyeth, announced that it has initiated a voluntary recall and replacement programme for all US retail outlets that sell several Robitussin products and Children's Dimetapp Cold & Chest Congestion.
The programme involves removal of existing products with a dosage cup that does not have a half-teaspoon mark, which is the recommended dose for children age two to under six. This action is specific to the dosage cup and not related to the medication itself. For children age two to under six, the company is advising consumers not to use these medicines until the replacement products with the new cup are available.
The replacement products with the new dosage cup are expected to be available beginning in early November 2007. Packaging for the replacement products will be marked to indicate that the new dosage cup is included.
The recall and replacement programme for these products does not affect other Robitussin and Dimetapp cough and cold products.
Products being recalled and replaced are robitussin for cough DM, robitussin for cough and cold CF, robitussin for cough and congestion, robitussin for chest congestion, robitussin head and chest congestion PE, robitussin cough sugar free DM, children's dimetapp cold and chest congestion.
Wyeth Consumer Healthcare, a division of Wyeth, is one of the world's leaders in the development, manufacturing and marketing of non-prescription medicines, vitamins and nutritional products, including established brands such as Advil, Centrum, ChapStick, Dimetapp and Robitussin.